David Loch

David has a diverse scientific background. He completed a veterinary degree at the University of Queensland (UQ). Early exposure to scientific research as an undergraduate student by way of Cornell University’s leadership program for veterinary students ultimately led him to complete a PhD from UQ, where his research was in the area of cardiovascular pharmacology.

Before joining the patent attorney profession, David spent nearly five years as a postdoctoral fellow in the Institute of Genetic Medicine at Johns Hopkins School of Medicine in Baltimore, United States of America. His research there focused on generating genetically engineered mouse models and identifying cell signalling pathways as potential targets for connective tissue disorders in humans. Upon returning to Australia, he conducted further post-doctoral research at Queensland University of Technology, where he investigated the development of gene-based resistance to molecularly targeted agents in cancer.

David’s practice focuses on the drafting and prosecution of global patent families across the life sciences field including diagnostics, vaccines, therapeutics, medical devices, biotechnology, and food and beverage technologies. He also specialises in the drafting and prosecution of Plant Breeders Rights applications for local and international clients. David works closely with companies, universities and researchers to capture their commercially valuable IP and he is well regarded for his ability to develop strong, collaborative relationships with his clients.

As a result of his scientific research, David has authored 16 peer reviewed articles and reviews in international journals.

David is a registered Australian and New Zealand Patent Attorney.